Journal article
Tromethamine improves mucociliary clearance in cystic fibrosis pigs
Physiological reports, Vol.10(17), pp.e15340-n/a
09/2022
DOI: 10.14814/phy2.15340
PMCID: PMC9453173
PMID: 36073059
Abstract
In cystic fibrosis (CF), the loss of cystic fibrosis transmembrane conductance regulator (CFTR) mediated Cl− and HCO3− secretion across the epithelium acidifies the airway surface liquid (ASL). Acidic ASL alters two key host defense mechanisms: Rapid ASL bacterial killing and mucociliary transport (MCT). Aerosolized tromethamine (Tham) increases ASL pH and restores the ability of ASL to rapidly kill bacteria in CF pigs. In CF pigs, clearance of insufflated microdisks is interrupted due to abnormal mucus causing microdisks to abruptly recoil. Aerosolizing a reducing agent to break disulfide bonds that link mucins improves MCT. Here, we are interested in restoring MCT in CF by aerosolizing Tham, a buffer with a pH of 8.4. Because Tham is hypertonic to serum, we use an acidified formulation as a control. We measure MCT by tracking the caudal movement of individual tantalum microdisks with serial chest computed tomography scans. Alkaline Tham improves microdisk clearance to within the range of that seen in non‐CF pigs. It also partially reverses MCT defects, including reduced microdisk recoil and elapse time until they start moving after methacholine stimulation in CF pig airways. The effect is not due to hypertonicity, as it is not seen with acidified Tham or hypertonic saline. This finding indicates acidic ASL impairs CF MCT and suggests that alkalinization of ASL pH with inhaled Tham may improve CF airway disease.
Cystic fibrosis airways are acidic and as a result, submucosal gland secretions are abnormally elastic. Tromethamine, a tris buffer with long‐lasting effect on pH, alkalinizes the airways and reverses mucociliary clearance defects in CF.
Details
- Title: Subtitle
- Tromethamine improves mucociliary clearance in cystic fibrosis pigs
- Creators
- Jamison J. Ash - University of IowaBrieanna M. Hilkin - University of IowaNicholas D. Gansemer - University of IowaEric A. Hoffman - University of IowaJoseph Zabner - Roy J. and Lucille A. Carver College of MedicineDavid A. Stoltz - Roy J. and Lucille A. Carver College of MedicineMahmoud H. Abou Alaiwa - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Physiological reports, Vol.10(17), pp.e15340-n/a
- DOI
- 10.14814/phy2.15340
- PMID
- 36073059
- PMCID
- PMC9453173
- NLM abbreviation
- Physiol Rep
- eISSN
- 2051-817X
- Number of pages
- 11
- Grant note
- National Heart, Lung, and Blood Institute (NIH K08 HL135433; NIH PPG HL051670; NIH PPG HL091842; NIH R01 HL136813) Cystic Fibrosis Foundation (ABOU20A0‐KB; STOLTZ16XX0; STOLTZ19R0)
- Language
- English
- Date published
- 09/2022
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Molecular Physiology and Biophysics; Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
- Record Identifier
- 9984297610602771
Metrics
16 Record Views